-transparent.png){kind=logo}
The Burkitt-like lymphoma is extremely rare. It shows a predominance of presentation in abdominal and pelvic sites and an older median age as compared to the endemic Burkitt's lymphoma. Both are independent prognostic determinants and reflect a poor prognosis. This might be the reason for the low response rate to cytotoxic treatment. Cyclophosphamide is a substantial part of any chemotherapeutic regimen used. Serum lactic dehydrogenase (LDH) levels are closely correlated with the extent of tumor mass and the response to therapy. Chemotherapy might be associated with serious metabolic complications including hyperkalemia, lactic acidosis, anuria, and sudden death from lethal embolization of the lung. In contrast to Burkitt's lymphoma, the Burkitt-like tumor has no association with the Epstein-Barr-virus. In both lymphomas a translocation from the 8q onto 14q chromosome occurs being a characteristic marker for these malignancies.
U Jehn, and
A Wohlrab, and
W Wilmanns
June 1976,
Anales espanoles de pediatria,
U Jehn, and
A Wohlrab, and
W Wilmanns
April 2010,
Clinical cancer research : an official journal of the American Association for Cancer Research,
U Jehn, and
A Wohlrab, and
W Wilmanns
January 1973,
International journal of cancer,
U Jehn, and
A Wohlrab, and
W Wilmanns
October 2011,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
U Jehn, and
A Wohlrab, and
W Wilmanns
October 1978,
Deutsche medizinische Wochenschrift (1946),
U Jehn, and
A Wohlrab, and
W Wilmanns
March 1980,
Deutsche medizinische Wochenschrift (1946),
U Jehn, and
A Wohlrab, and
W Wilmanns
April 1981,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
U Jehn, and
A Wohlrab, and
W Wilmanns
April 1977,
British journal of cancer,
U Jehn, and
A Wohlrab, and
W Wilmanns
June 2019,
Blood,
U Jehn, and
A Wohlrab, and
W Wilmanns
February 1980,
Neurologia medico-chirurgica,
